Aprea Therapeutics, Inc.
APRE
$0.80
-$0.04-4.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.59M | -3.29M | -2.46M | -2.97M | -3.24M |
| Total Depreciation and Amortization | 5.70K | 5.40K | 5.40K | 5.40K | 5.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.20K | 93.40K | 156.80K | 119.40K | 165.90K |
| Change in Net Operating Assets | 206.60K | 432.40K | -667.90K | -323.70K | -63.20K |
| Cash from Operations | -3.28M | -2.76M | -2.96M | -3.17M | -3.13M |
| Capital Expenditure | -15.40K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -15.40K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 500.10K | 35.10M | 4.21M | 375.40K | 399.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.44M | -474.70K | -371.70K | -17.40K | -14.90K |
| Cash from Financing | -1.94M | 34.62M | 3.84M | 357.90K | 384.90K |
| Foreign Exchange rate Adjustments | -700.00 | -300.00 | 1.30K | -600.00 | 2.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.23M | 31.87M | 881.60K | -2.81M | -2.74M |